Cairo Pharmaceuticals (CPCI.CA) - Disclosure Form Concerning the BoD & the Shareholders' Structure
Company Name : Cairo Pharmaceuticals
ISIN Code : EGS38391C016
Reuters Code : CPCI.CA
Content :
The company sent its Disclosure Form for the BoD & the shareholders' structure for the period ended 31/03/2024, according to Article 30 of the Listing Rules.
The Disclosure Form (569 KB)
ISIN Code : EGS38391C016
Reuters Code : CPCI.CA
Content :
The company sent its Disclosure Form for the BoD & the shareholders' structure for the period ended 31/03/2024, according to Article 30 of the Listing Rules.
The Disclosure Form (569 KB)
Comments